Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
plerixafor (mozobil) (1 trial)
sargramostim (leukine) (1 trial)
Anemia (Phase 2)
Fanconi Anemia (Phase 2)
Fanconi Syndrome (Phase 2)
Trials (1 total)
Trial APIs (2 total)